Clinical Effects of Whole-body Hyperthermia in Advanced Malignancy

Pettigrew, R. T.; Galt, Jean M.; Ludgate, C. M.; Smith, A. N.
December 1974
British Medical Journal;12/21/1974, Vol. 4 Issue 5946, p679
Academic Journal
No abstract available.


Related Articles

  • Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers. Healy, J.M. Sandra; Heffron, James J.A.; Lehane, Mary; Bradley, Dan G.; Johnson, Keith; McCarthy, Tommie V. // BMJ: British Medical Journal (International Edition);11/16/91, Vol. 303 Issue 6812, p1225 

    Examines the use of flanking DNA markers in diagnosing malignant hyperthermia susceptibility in Cork, Ireland. Categorization of malignant hyperthermia; Generation of the genetic typing of polymorphic DNA markers; Clinical diagnosis of malignant hyperthermia.

  • The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis. Tarner, Ingo H.; Müller-Ladner, Ulf; Uhlemann, Christine; Lange, Uwe // Clinical Rheumatology;Apr2009, Vol. 28 Issue 4, p397 

    Serial mild whole-body hyperthermia is a widely used balneotherapy modality for clinically inactive ankylosing spondylitis (AS) in rehabilitative medicine. Thus far, the mechanisms of its favorable influence on the symptoms of AS are not completely understood. We therefore analyzed the effect of...

  • Genetics and Susceptibility to Malignant Hyperthermia. Anderson-Pompa, Kathryn; Foster, April; Parker, Lee; Wilks, Lance; Cheek, Dennis J. // Critical Care Nurse;Dec2008, Vol. 28 Issue 6, p32 

    The article explores genetics and genomics in the context of the pathophysiology of malignant hyperthermia. It explains why it is essential for critical care nurses to understand the impact of genetics on their practice. It discusses the role of autosomal dominant pharmacogenetic trait in one's...

  • Hipertermia maligna. Conceptos actuales. Carrillo-Esper, Raúl; Lázaro-Santiago, Gabriela; Nava-López, Jorge Arturo // Revista Mexicana de Anestesiologia;jul-sep2013, Vol. 36 Issue 3, p185 

    Malignant hyperthermia is a pharmacogenetic musculoskeletal disorder. Patients with malignant hyperthermia experience exaggerated metabolic response when exposed to certain triggers such as volatile anesthetics and succinylcholine. The incidence of malignant hyperthermia ranges from 1:5,000 to...

  • Hyperthermia for Major Depressive Disorder?-Reply. Raison, Charles L.; Janssen, Clemens W.; Lowry, Christopher A. // JAMA Psychiatry;Oct2016, Vol. 73 Issue 10, p1095 

    A response from the authors of the article "Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial" which was published online on September 14, 2016 is presented.

  • Hyperthermia for Major Depressive Disorder? Fink, Max; Shorter, Edward // JAMA Psychiatry;Oct2016, Vol. 73 Issue 10, p1096 

    A letter to the editor is presented in response to the article "Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial" by Clemens W. Janssen and colleagues which appeared online on September 14, 2016.

  • Current Status and Perspectives of Hyperthermia in Cancer Therapy. Hiraoka, Masahiro; Nagata, Yasushi; Mitsumori, Michihide; Sakamoto, Masashi; Masunaga, Shin-ichiro // AIP Conference Proceedings;2004, Vol. 716 Issue 1, p102 

    Clinical trials of hyperthermia in combination with radiation therapy or chemotherapy undertaken over the past decades in Japan have been reviewed. Originally developed heating devices were mostly used for these trials, which include RF (radiofrequency) capacitive heating devices, a microwave...

  • Tumor oxygenation under combined whole-body-hyperthermia and polychemotherapy in a case of recurrent carcinoma of the oral cavity. Sagowski, C.; Jaehne, Michael; Kehrl, Wolfgang; Hegewisch-Becker, Susanna; Wenzel, Sören; Panse, Jens; Nierhaus, Axel // European Archives of Oto-Rhino-Laryngology;Jan2002, Vol. 259 Issue 1, p27 

    Background: Previous studies have reported synergistic effects of combined hyperthermia and chemotherapy and/or irradiation. The discussed underlying mechanism for this effect is an synergistic cytotoxic and radiosensitizing effect of hyperthermia. In addition, tumor blood-flow and,...

  • Detecting susceptibility to malignant hyperthermia. Ellis, F. Richard // BMJ: British Medical Journal (International Edition);3/28/92, Vol. 304 Issue 6830, p791 

    Focuses on the importance of genetic tests and better communication among family member in detecting susceptibility to hyperthermia. Benefits of blood test using DNA in distinguishing various syndrome related to malignant hyperthermia; Implication of the gene for ryanodine receptor on the...

  • Whole-body hyperthermia: a review of theory, design and application. Vertrees, Roger A; Leeth, Angela; Girouard, Mark; Roach, John D; Zwischenberger, Joseph B // Perfusion;Jul2002, Vol. 17 Issue 4, p279 

    The intentional induction of elevated body temperature to treat malignant lesions has its origins in the 18th century. The mechanism of heat-induced cell death is not clear; however, heat induces a variety of cellular changes. For heat to exert a therapeutic effect, pathogens (bacteria, viruses,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics